Efficacy and safety of Boceprevir-based therapy in HCVG1 treatment-experienced patients with advanced fibrosis/cirrhosis: Italian NPP survey
Savino Bruno(Humanitas University), V. Di Marco(University of Palermo), Marco Massari(Azienda Sanitaria Unità Locale di Reggio Emilia), Alessandra Mangia(Casa Sollievo della Sofferenza), Anna Licata(University of Palermo), Valeria Piazzolla(Casa Sollievo della Sofferenza), Vincenza Calvaruso(University of Palermo), Gaetano Serviddio(University of Foggia), Simona Landonio(ASST Fatebenefratelli Sacco), Luigi Muratori(University of Bologna), Anna Linda Zignego(University of Florence), Sara Piovesan, Sergio Babudieri(University of Sassari), Maurizio Russello(Ospedale Garibaldi), E. Marchionne(Azienda Ospedaliero-Universitaria delle Marche), Francesca Farina(University of Palermo), Stefano Fangazio, Alessandra Moretti(TUM Klinikum), C. Colletta, Alessia Ciancio(Department of Medical Sciences), Massimo Zuin(AOL (United States)), Teresa Santantonio(Ospedali Riuniti di Foggia), S. Bollani(Azienda Ospedaliera Fatebenefratelli e Oftalmico), Antonio Craxı̀(University of Palermo), Alberto Colombo(University of Illinois Chicago), Francesco Mazzotta(Ospedale SS. Annunziata), Marcello Caremani(Azienda Usl 8 Arezzo), M. Rizzetto(National Institutes of Health), Alberto Traverso(University of Genoa), C. Magni(ASST Fatebenefratelli Sacco), Luisa Cavalletto(University of Padua)
Cited by 1
Related Papers
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
|New England Journal of Medicine|2010|1.2k
Searching for an Operational Definition of Frailty: A Delphi Method Based Consensus Statement. The Frailty Operative Definition-Consensus Conference Project
|The Journals of Gerontology Series A|2012|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998